https://pfk158inhibitor.com/in....vestigation-subgingi
For this investigation, a retrospective cohort study approach was adopted. We examined the demographic characteristics of patients, including age and **** distribution, alongside their primary diseases, and assessed the incidence and duration of abnormal blood coagulation following cefoperazone-sulbactam treatment. The chi-square and t-tests were utilized to investigate the effects of cefoperazone sulbactam on coagulation function and vitamin K intervention on the patient
Like
Comment
Share
